BioCentury | Feb 24, 2017
Finance

IPO for evergreen

...therapy company Autolus Ltd. , genomics company Depixus S.A.S. , ophthalmic, endocrine/metabolic and neurology play OptiKira LLC...
BioCentury | Feb 17, 2017
Financial News

Arix raises L100M in IPO

...life science companies worldwide. Its portfolio includes Autolus Ltd. (London, U.K.), Depixus S.A.S. (Paris, France), OptiKira LLC...
BioCentury | Feb 2, 2017
Financial News

Life sciences investor Arix planning L100M listing

...worldwide. Arix’s portfolio already includes five companies: Autolus Ltd. (London, U.K.), Depixus S.A.S. (Paris, France), OptiKira LLC...
BioCentury | Feb 9, 2015
Company News

BioMotiv, Optikira LLC, UCSF, University of Washington endocrine/metabolic, ophthalmic news

...or unfolded proteins. Optikira holds an exclusive license to IP developed at the two universities. Optikira...
...the grant or how much funding Optikira has raised. According to a December SEC filing, Optikira...
...of Optikira’s board, as is UCSF associate professor Scott Oakes. BioMotiv LLC , Cleveland, Ohio Optikira LLC...
BioCentury | Feb 3, 2015
Company News

BioMotiv, two universities launch Optikira

...Ohio), the University of California San Francisco , and the University of Washington launched newco Optikira LLC...
...or unfolded proteins. Optikira holds an exclusive license to IP developed at the two universities. Optikira...
...Optikira has raised the first $250,000 of a planned $5 million equity round. Auvil said Optikira...
Items per page:
1 - 5 of 5
BioCentury | Feb 24, 2017
Finance

IPO for evergreen

...therapy company Autolus Ltd. , genomics company Depixus S.A.S. , ophthalmic, endocrine/metabolic and neurology play OptiKira LLC...
BioCentury | Feb 17, 2017
Financial News

Arix raises L100M in IPO

...life science companies worldwide. Its portfolio includes Autolus Ltd. (London, U.K.), Depixus S.A.S. (Paris, France), OptiKira LLC...
BioCentury | Feb 2, 2017
Financial News

Life sciences investor Arix planning L100M listing

...worldwide. Arix’s portfolio already includes five companies: Autolus Ltd. (London, U.K.), Depixus S.A.S. (Paris, France), OptiKira LLC...
BioCentury | Feb 9, 2015
Company News

BioMotiv, Optikira LLC, UCSF, University of Washington endocrine/metabolic, ophthalmic news

...or unfolded proteins. Optikira holds an exclusive license to IP developed at the two universities. Optikira...
...the grant or how much funding Optikira has raised. According to a December SEC filing, Optikira...
...of Optikira’s board, as is UCSF associate professor Scott Oakes. BioMotiv LLC , Cleveland, Ohio Optikira LLC...
BioCentury | Feb 3, 2015
Company News

BioMotiv, two universities launch Optikira

...Ohio), the University of California San Francisco , and the University of Washington launched newco Optikira LLC...
...or unfolded proteins. Optikira holds an exclusive license to IP developed at the two universities. Optikira...
...Optikira has raised the first $250,000 of a planned $5 million equity round. Auvil said Optikira...
Items per page:
1 - 5 of 5